Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen.
Per Med
; 10(6): 601-611, 2013 Aug.
Article
en En
| MEDLINE
| ID: mdl-29776195
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Health_technology_assessment
/
Prognostic_studies
Idioma:
En
Año:
2013
Tipo del documento:
Article